Free Trial

B. Metzler seel. Sohn & Co. AG Has $1.45 Million Stock Position in Healthpeak Properties, Inc. $DOC

Healthpeak Properties logo with Finance background

Key Points

  • B. Metzler seel. Sohn & Co. AG reduced its stake in Healthpeak Properties, Inc. by 30.9%, selling 32,000 shares and now holding 71,508 shares valued at approximately $1,446,000.
  • Healthpeak Properties announced a recent monthly dividend of $0.1017 per share, yielding about 6.8%, with an exceptional dividend payout ratio of 508.33%.
  • Several institutional investors have made significant changes to their positions in Healthpeak, with 93.57% of the stock currently owned by institutional investors, indicating strong institutional support.
  • Five stocks to consider instead of Healthpeak Properties.

B. Metzler seel. Sohn & Co. AG lessened its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 30.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 71,508 shares of the real estate investment trust's stock after selling 32,000 shares during the period. B. Metzler seel. Sohn & Co. AG's holdings in Healthpeak Properties were worth $1,446,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Machina Capital S.A.S. grew its position in shares of Healthpeak Properties by 62.8% in the 1st quarter. Machina Capital S.A.S. now owns 37,160 shares of the real estate investment trust's stock valued at $751,000 after acquiring an additional 14,336 shares during the period. Douglas Lane & Associates LLC grew its position in shares of Healthpeak Properties by 8.5% in the 1st quarter. Douglas Lane & Associates LLC now owns 2,792,850 shares of the real estate investment trust's stock valued at $56,471,000 after acquiring an additional 218,395 shares during the period. Cambridge Investment Research Advisors Inc. grew its position in shares of Healthpeak Properties by 6.9% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 357,520 shares of the real estate investment trust's stock valued at $7,229,000 after acquiring an additional 23,135 shares during the period. Ibex Wealth Advisors bought a new stake in shares of Healthpeak Properties during the 1st quarter worth about $5,056,000. Finally, Vert Asset Management LLC boosted its holdings in shares of Healthpeak Properties by 6.9% during the 1st quarter. Vert Asset Management LLC now owns 325,143 shares of the real estate investment trust's stock worth $6,574,000 after buying an additional 20,924 shares during the period. Institutional investors own 93.57% of the company's stock.

Healthpeak Properties Stock Performance

NYSE DOC traded up $0.27 during trading on Thursday, reaching $18.00. The company's stock had a trading volume of 4,875,510 shares, compared to its average volume of 6,198,658. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.06. The firm has a market capitalization of $12.51 billion, a price-to-earnings ratio of 75.00, a price-to-earnings-growth ratio of 2.28 and a beta of 1.07. Healthpeak Properties, Inc. has a 12 month low of $16.63 and a 12 month high of $23.26. The firm has a 50 day moving average price of $17.73 and a 200 day moving average price of $18.26.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting the consensus estimate of $0.46. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The company had revenue of $694.35 million during the quarter, compared to analysts' expectations of $697.14 million. During the same period in the previous year, the company earned $0.45 EPS. The business's revenue for the quarter was down .2% compared to the same quarter last year. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, equities analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The company also recently declared a monthly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 18th were issued a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a dividend yield of 6.8%. The ex-dividend date of this dividend was Monday, August 18th. Healthpeak Properties's dividend payout ratio is 508.33%.

Insider Buying and Selling at Healthpeak Properties

In other Healthpeak Properties news, CEO Scott M. Brinker purchased 1,490 shares of the firm's stock in a transaction dated Monday, August 4th. The shares were bought at an average price of $16.83 per share, for a total transaction of $25,076.70. Following the purchase, the chief executive officer owned 211,906 shares in the company, valued at approximately $3,566,377.98. This trade represents a 0.71% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Over the last ninety days, insiders have purchased 8,783 shares of company stock worth $150,129. Corporate insiders own 0.23% of the company's stock.

Analyst Ratings Changes

Several analysts recently commented on the stock. Morgan Stanley reduced their target price on shares of Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating for the company in a report on Friday, August 22nd. Robert W. Baird set a $21.00 target price on shares of Healthpeak Properties and gave the stock an "outperform" rating in a report on Wednesday, July 30th. Scotiabank downgraded shares of Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and reduced their target price for the stock from $21.00 to $19.00 in a report on Tuesday, July 29th. Wall Street Zen downgraded shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Monday, July 7th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and set a $18.00 target price (down previously from $28.00) on shares of Healthpeak Properties in a report on Wednesday, August 20th. Seven research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, Healthpeak Properties currently has a consensus rating of "Moderate Buy" and an average target price of $21.50.

Read Our Latest Stock Report on Healthpeak Properties

About Healthpeak Properties

(Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

See Also

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Should You Invest $1,000 in Healthpeak Properties Right Now?

Before you consider Healthpeak Properties, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.

While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.